14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.500 $0.700 Thursday, 2nd May 2024 ADXS stock ended at $0.531. This is 17.51% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 17.53% from a day low at $0.519 to a day high of $0.610.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Dec 10, 2021 $0.372 $0.377 $0.320 $0.325 3 046 567
Dec 09, 2021 $0.369 $0.382 $0.347 $0.348 2 406 638
Dec 08, 2021 $0.343 $0.366 $0.340 $0.360 1 676 960
Dec 07, 2021 $0.354 $0.380 $0.350 $0.354 2 869 193
Dec 06, 2021 $0.313 $0.348 $0.301 $0.345 2 766 636
Dec 03, 2021 $0.344 $0.348 $0.310 $0.311 2 868 192
Dec 02, 2021 $0.341 $0.353 $0.338 $0.344 1 852 248
Dec 01, 2021 $0.370 $0.373 $0.330 $0.344 3 378 899
Nov 30, 2021 $0.400 $0.410 $0.365 $0.370 3 263 075
Nov 29, 2021 $0.390 $0.420 $0.362 $0.400 8 346 462
Nov 26, 2021 $0.376 $0.390 $0.365 $0.385 1 654 023
Nov 24, 2021 $0.367 $0.420 $0.360 $0.402 5 410 390
Nov 23, 2021 $0.380 $0.380 $0.350 $0.362 1 863 892
Nov 22, 2021 $0.381 $0.389 $0.351 $0.368 3 299 475
Nov 19, 2021 $0.379 $0.390 $0.370 $0.377 2 981 197
Nov 18, 2021 $0.402 $0.404 $0.366 $0.368 4 458 738
Nov 17, 2021 $0.415 $0.418 $0.393 $0.404 2 562 492
Nov 16, 2021 $0.410 $0.426 $0.382 $0.415 5 399 625
Nov 15, 2021 $0.444 $0.449 $0.405 $0.409 6 657 079
Nov 12, 2021 $0.443 $0.448 $0.431 $0.444 2 585 751
Nov 11, 2021 $0.455 $0.457 $0.430 $0.437 4 514 170
Nov 10, 2021 $0.477 $0.479 $0.441 $0.455 7 506 224
Nov 09, 2021 $0.490 $0.494 $0.475 $0.479 7 419 535
Nov 08, 2021 $0.490 $0.498 $0.473 $0.477 4 318 729
Nov 05, 2021 $0.499 $0.509 $0.484 $0.492 6 117 980
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT